This post is from a suggested group
Regulation and Quality Assurance for Veterinary Biologics and Animal Health
The successful delivery of veterinary biologics—a category encompassing vaccines, diagnostic kits, and antisera—is heavily dependent on stringent regulatory oversight to ensure the purity, safety, and efficacy of products used in animal health. Agencies like the Center for Veterinary Biologics (CVB) enforce quality standards based on acts such as the Virus-Serum-Toxin Act, which governs the manufacture and distribution of these essential products for livestock and companion animals. This regulatory framework is key to managing animal disease, which in turn supports food security and public health. Ongoing activities include licensing, the review of adverse event reports, and working toward international harmonization of standards to facilitate global trade and quality assurance for animal medical products.